Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women

[11] Cullen P(1998)Profiles socio-démographique, clinique, biologique et nutritionnel d'une population de femmes marocaines, obèses, en âge de procréer et issue de la même région Diabetes & Metabolism 24 p29, p104-1987

[12] Bao W(1996)Differences in mortality and morbidity in African Caribbean and European people with non-insulin dependent diabetes mellitus: results of 20 y follow up of a London cohort of a multinational study BMJ 313 848-21

[13] Srinivasan SR(1992)Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group CMAJ 146 1977-1163

[14] Wattigney WA(1988)Apolipoprotein E polymorphism and atherosclerosis Atherosclerosis 8 1-148

[15] Berenson GS(1991)La cholestérolémie en France Concours Méd. 113 1162-408

[16] Barrett-Connor E(1980)Immunochemical determination of human apolipoprotein A-I by laser nephelometry Clin. Chim. Acta 107 145-2080

[17] Khaw K(1979)Immunochemical determination of human apolipoprotein B by laser nephelometry Clin. Chim. Acta 95 405-170

[18] Belahsen R(1982)Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide Clin. Chem. 28 2077-1432

[19] Mziwira M(2001)Coronary artery disease in patients at low risk: apolipoprotein AI as an independent risk factor Atherosclerosis 155 165-502

[20] Fertat F(1997)Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions J. Lipid. Res. 38 1421-1376

[11] Cullen P(1998)Profiles socio-démographique, clinique, biologique et nutritionnel d'une population de femmes marocaines, obèses, en âge de procréer et issue de la même région Diabetes & Metabolism 24 p29, p104-1987

[12] Bao W(1996)Differences in mortality and morbidity in African Caribbean and European people with non-insulin dependent diabetes mellitus: results of 20 y follow up of a London cohort of a multinational study BMJ 313 848-21

[13] Srinivasan SR(1992)Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group CMAJ 146 1977-1163

[14] Wattigney WA(1988)Apolipoprotein E polymorphism and atherosclerosis Atherosclerosis 8 1-148

[15] Berenson GS(1991)La cholestérolémie en France Concours Méd. 113 1162-408

[16] Barrett-Connor E(1980)Immunochemical determination of human apolipoprotein A-I by laser nephelometry Clin. Chim. Acta 107 145-2080

[17] Khaw K(1979)Immunochemical determination of human apolipoprotein B by laser nephelometry Clin. Chim. Acta 95 405-170

[18] Belahsen R(1982)Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide Clin. Chem. 28 2077-1432

[19] Mziwira M(2001)Coronary artery disease in patients at low risk: apolipoprotein AI as an independent risk factor Atherosclerosis 155 165-502

[20] Fertat F(1997)Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions J. Lipid. Res. 38 1421-1376